ZIVO Bioscience Past Earnings Performance

Past criteria checks 0/6

ZIVO Bioscience has been growing earnings at an average annual rate of 10.5%, while the Personal Products industry saw earnings growing at 10.2% annually. Revenues have been growing at an average rate of 14.7% per year.

Key information

10.5%

Earnings growth rate

46.8%

EPS growth rate

Personal Products Industry Growth20.9%
Revenue growth rate14.7%
Return on equityn/a
Net Margin-28,127.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

ZIVO Bioscience: Building An IP Portfolio For Algal Biomass Derived Ingredients

Nov 25

Revenue & Expenses Breakdown
Beta

How ZIVO Bioscience makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ZIVO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-861
30 Sep 230-962
30 Jun 230-962
31 Mar 230-972
31 Dec 220-962
30 Sep 220-972
30 Jun 220-972
31 Mar 220-972
31 Dec 210-972
30 Sep 210-752
30 Jun 210-963
31 Mar 210-953
31 Dec 200-954
30 Sep 200-1174
30 Jun 200-1063
31 Mar 200-1164
31 Dec 190-1262
30 Sep 190-1042
30 Jun 190-1342
31 Mar 190-1432
31 Dec 180-1533
30 Sep 180-1543
30 Jun 180-1443
31 Mar 180-1243
31 Dec 170-1042
30 Sep 170-732
30 Jun 170-621
31 Mar 170-731
31 Dec 160-631
30 Sep 160-631
30 Jun 160-631
31 Mar 160-621
31 Dec 150-621
30 Sep 150-421
30 Jun 150-622
31 Mar 150-522
31 Dec 140122
30 Sep 140022
30 Jun 140-121
31 Mar 140-521
31 Dec 130-1021
30 Sep 130-1121

Quality Earnings: ZIVO is currently unprofitable.

Growing Profit Margin: ZIVO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ZIVO is unprofitable, but has reduced losses over the past 5 years at a rate of 10.5% per year.

Accelerating Growth: Unable to compare ZIVO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZIVO is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (3.4%).


Return on Equity

High ROE: ZIVO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.